Standard BioTools Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2016 | 62.8% | -65.1% | -68.6% |
| Jun 2016 | 60.1% | -64.4% | -66.1% |
| Sep 2016 | 59.1% | -83.3% | -89.2% |
| Dec 2016 | 222.8% | -70.5% | -70.5% |
| Mar 2017 | 57.5% | -68.7% | -67.4% |
| Jun 2017 | 54.9% | -68.9% | -70.8% |
| Sep 2017 | 53.9% | -63.0% | -64.4% |
| Dec 2017 | 39.1% | -31.5% | -37.7% |
| Mar 2018 | 53.2% | -50.0% | -52.5% |
| Jun 2018 | 51.4% | -48.4% | -61.5% |
| Sep 2018 | 54.6% | -40.1% | -50.9% |
| Dec 2018 | 58.2% | -34.4% | -45.7% |
| Mar 2019 | 56.4% | -47.2% | -84.6% |
| Jun 2019 | 54.5% | -51.9% | -48.8% |
| Sep 2019 | 52.2% | -52.1% | -48.6% |
| Dec 2019 | 54.1% | -28.3% | -39.1% |
| Mar 2020 | 47.1% | -54.1% | -57.9% |
| Jun 2020 | 45.4% | -52.7% | -49.9% |
| Sep 2020 | 52.2% | -13.7% | -15.0% |
| Dec 2020 | 49.5% | -37.9% | -40.4% |
| Mar 2021 | — | -58.9% | -57.4% |
| Jun 2021 | — | -55.7% | -55.3% |
| Sep 2021 | — | -68.8% | -48.6% |
| Dec 2021 | — | -29.4% | -24.6% |
| Mar 2022 | — | -103.8% | -287.8% |
| Jun 2022 | 23.6% | -205.4% | -338.4% |
| Sep 2022 | 36.0% | -113.2% | -114.7% |
| Dec 2022 | — | -78.1% | -77.1% |
| Mar 2023 | 48.9% | -66.1% | -67.1% |
| Jun 2023 | 49.2% | -63.1% | -61.6% |
| Sep 2023 | 44.0% | -83.5% | -82.8% |
| Dec 2023 | 47.6% | -75.9% | -70.2% |
| Mar 2024 | 53.1% | -132.2% | -70.6% |
| Jun 2024 | 46.1% | -134.5% | -203.3% |
| Sep 2024 | 54.9% | -120.9% | -122.0% |
| Dec 2024 | -202.8% | -1,162.1% | -3,828.3% |
| Mar 2025 | 54.6% | -133.4% | -128.7% |
| Jun 2025 | 48.8% | -118.1% | -153.7% |
| Sep 2025 | 48.5% | -168.5% | -177.4% |
| Dec 2025 | 47.8% | -103.6% | 81.0% |
| Mar 2026 | 53.5% | -59.1% | 600.9% |
| Jun 2026 | 52.4% | -126.3% | -133.1% |